THUY-LINH NGUYEN: Open Payments
NPI 1730642034 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,402 in 81 payments from 18 companies in 2025. Trend: 2023 $2,329 · 2024 $2,994 · 2025 $3,402
Food & beverage: $3,402
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 29 | $760 |
| Teva Pharmaceuticals USA, Inc. | 9 | $402 |
| Otsuka America Pharmaceutical, Inc. | 9 | $315 |
| Alkermes, Inc. | 4 | $295 |
| ABBVIE INC. | 8 | $262 |
| E.R. Squibb & Sons, L.L.C. | 4 | $217 |
| ViiV Healthcare Company | 3 | $210 |
| SANOFI-AVENTIS U.S. LLC | 1 | $146 |
| Novo Nordisk Inc | 2 | $134 |
| Insulet Corporation | 1 | $125 |
Products named: ABILIFY MAINTENA, UZEDY, COBENFY, CABENUVA, VRAYLAR, Vemlidy, TZIELD, AUSTEDO XR.
Industry payments across HI — which companies pay providers there.
